e a good day. - Daily Commentary - One of our pet peeves is people detecting patterns where there may be none. Reading the following article about Allergen takeover volume spike (Flurry of Allergan Trading Preceded Offer) is a case in point. And this is not say the article or the analysis (especially s

e a good day. - Daily Commentary - One of our pet peeves is people detecting patterns where there may be none. Reading the following article about Allergen takeover volume spike (Flurry of Allergan Trading Preceded Offer) is a case in point. And this is not say the article or the analysis (especially s

version ratio sliding scale, can result in an attractively skewed upside vs downside profile for holding the mandatory convert vs the common stock. Allergen, Teva and Frontier Communications are three names we have high conviction on and they have mandatory convert preferreds that I recommend buying. All

version ratio sliding scale, can result in an attractively skewed upside vs downside profile for holding the mandatory convert vs the common stock. Allergen, Teva and Frontier Communications are three names we have high conviction on and they have mandatory convert preferreds that I recommend buying. All

footprint, thoughtful and targeted strategy, strong management team, and imaginative business development approach. We believe the acquisitions of Allergen, Warner and Forest put Irish•domiciled AGN in a strong strategic and financial position for an evolving Pharma landscape in the years ahead. Teva P